RE: Inflection points30 Sep 2025 11:42
From mid August trading update
“We continue to make good progress on existing Joint Development Agreements ("JDAs"), with discussions ongoing regarding an extension to the JDA with one of our Asian Chemical customers before the expiry of the existing contract, which is due to complete in October 2025;”
Great if they move to the next phase..not so much if they don’t!
Then there is always
“Discussions are ongoing in relation to potential further JDAs with a number of other companies, some of which are outside of historical Nanoco markets;”
But really the outcome of the CDX process at some point in time is the only real inflection point that might really move the valuation…one way or the other. Starting to discount a negative outcome ..might not be the case?